Connect Biopharma Holdings Limited
CNTB
$0.7901
-$0.0099-1.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.79% | -20.79% | -15.93% | -20.37% | -22.41% |
| Total Receivables | 199.43% | 199.43% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -44.11% | -44.11% | -14.00% | -18.54% | 16.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -1.85% | -1.85% | -- | -- | -- |
| Total Current Assets | -20.88% | -20.88% | -15.81% | -20.26% | -21.33% |
|
|
|||||
| Total Current Assets | -20.88% | -20.88% | -15.81% | -20.26% | -21.33% |
| Net Property, Plant & Equipment | -10.54% | -10.54% | -11.16% | -15.85% | -44.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -14.52% | -14.52% | -11.63% | -16.30% | -13.89% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.50% | 37.50% | -86.94% | -87.63% | -90.48% |
| Total Assets | -20.48% | -20.48% | -16.01% | -20.45% | -26.80% |
|
|
|||||
| Total Accounts Payable | -84.52% | -84.52% | -50.33% | -52.96% | -81.49% |
| Total Accrued Expenses | -19.62% | -19.62% | 60.12% | 51.66% | 217.04% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -45.96% | -45.96% | -6.91% | -11.83% | 53.23% |
| Total Finance Division Other Current Liabilities | -96.92% | -96.92% | -55.54% | -57.89% | 2,395.72% |
| Total Other Current Liabilities | -96.92% | -96.92% | -55.54% | -57.89% | 2,395.72% |
| Total Current Liabilities | -66.54% | -66.54% | -35.30% | -38.72% | 61.89% |
|
|
|||||
| Total Current Liabilities | -66.54% | -66.54% | -35.30% | -38.72% | 61.89% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -86.67% | -86.67% | -77.29% | -78.49% | -26.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 56.05% | 56.05% | 143.66% | 130.68% | -37.88% |
| Total Liabilities | -64.77% | -64.77% | -34.29% | -37.77% | 56.64% |
|
|
|||||
| Common Stock & APIC | 1.61% | 1.61% | 11.38% | 5.50% | -31.22% |
| Retained Earnings | -4.74% | -4.74% | -13.84% | -7.83% | 31.28% |
| Treasury Stock & Other | -55.39% | -55.39% | -56.59% | -58.88% | -113.71% |
| Total Common Equity | -9.19% | -9.19% | -13.82% | -18.37% | -35.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -9.19% | -9.19% | -13.82% | -18.37% | -35.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -9.19% | -9.19% | -13.82% | -18.37% | -35.55% |
|
|
|||||